SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Brolin Elin B.)
 

Sökning: WFRF:(Brolin Elin B.) > Antiphospholipid an...

Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries

Svenungsson, Elisabet (författare)
Karolinska Institutet,Karolinska University Hospital
Spaak, Jonas (författare)
Karolinska Institutet,Danderyd Hospital
Strandberg, Karin (författare)
Lund University,Lunds universitet,Klinisk kemi, Malmö,Forskargrupper vid Lunds universitet,Clinical Chemistry, Malmö,Lund University Research Groups,Regional Laboratories Region Skåne
visa fler...
Wallén, Håkan N. (författare)
Karolinska Institutet,Danderyd Hospital
Agewall, Stefan (författare)
Karolinska Institutet,Oslo university hospital
Brolin, Elin B. (författare)
Karolinska Institutet,Capio St. Görans Sjukhus
Collste, Olov (författare)
Karolinska Institute
Daniel, Maria (författare)
Karolinska Institute
Ekenbäck, Christina (författare)
Karolinska Institutet,Danderyd Hospital
Frick, Mats (författare)
Karolinska Institutet,Karolinska Institute
Henareh, Loghman (författare)
Karolinska Institutet,Karolinska University Hospital
Malmqvist, Karin (författare)
Danderyd Hospital
Elvin, Kerstin (författare)
Karolinska University Hospital
Sörensson, Peder (författare)
Karolinska Institutet,Karolinska University Hospital
Y-Hassan, Shams (författare)
Karolinska University Hospital
Hofman-Bang, Claes (författare)
Danderyd Hospital
Tornvall, Per (författare)
Karolinska Institutet,Karolinska Institute
visa färre...
 (creator_code:org_t)
2021-11-24
2022
Engelska.
Ingår i: Journal of Internal Medicine. - : Wiley. - 0954-6820 .- 1365-2796. ; 291:3, s. 327-337
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: Recent studies demonstrate that prothrombotic antiphospholipid antibodies (aPL) are overrepresented in patients with myocardial infarction (MI) due to coronary artery disease (MICAD). However, it is not known whether aPL differ between the two subsets of MI: MICAD and MI with nonobstructive coronary arteries (MINOCA). Objectives: To determine whether aPL are associated with MINOCA or MICAD, or with hypercoagulability as assessed by activated protein C–protein C inhibitor (APC–PCI) complex. Methods: Well-characterized patients with MINOCA (n = 98), age- and gender-matched patients with MICAD (n = 99), and healthy controls (n = 100) were included in a cross-sectional case–control study. Autoantibodies (IgA/G/M) targeting cardiolipin and β2glycoprotein-I and specific nuclear antigens were analyzed by multiplexed bead technology. The concentration of APC–PCI was determined as a measure of hypercoagulability by an immunofluorometric sandwich assay. Results: Both prevalence and titers of aPL of the IgG isotype (anti-cardiolipin and/or anti-β2glycoprotein-I) were higher in patients with MINOCA and MICAD than in controls. aPL IgG positivity was twice as frequent among patients with MICAD than MINOCA (11% vs. 6%, nonsignificant). We observed no group differences regarding aPL IgA/M or antibodies targeting specific nuclear antigens. Levels of APC–PCI were elevated in aPL IgG-positive compared to aPL IgG-negative MICAD patients. Conclusions: aPL IgG, but not IgA/M, are enriched particularly in patients with MICAD but also in patients with MINOCA, as compared to controls. Interestingly, signs of hypercoagulability—measured by increased levels of the APC–PCI complex—were present in aPL IgG-positive MICAD patients, indicating an association with functional disturbances of the coagulation system.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Reumatologi och inflammation (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Rheumatology and Autoimmunity (hsv//eng)

Nyckelord

antiphospholipid antibodies
arteriosclerosis
cardiovascular risk factors
coagulation
immunology
myocardial infarction

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy